5.3(top 2%)
Impact Factor
5.7(top 2%)
extended IF
113(top 3%)
H-Index
6.1K
authors
14.8K
papers
140.7K
citations
5.3K
citing journals
93.8K
citing authors

Most Cited Articles of Frontiers in Oncology

TitleYearCitations
Targeting PI3K/Akt/mTOR Signaling in Cancer2014773
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations2018529
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis2015414
Radiation-induced brain injury: A review2012371
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi2018356
Trastuzumab: updated mechanisms of action and resistance in breast cancer2012315
Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment2014294
DNA methyltransferases: a novel target for prevention and therapy2014293
Mitochondrial dysfunction in cancer2013293
PTEN: Multiple Functions in Human Malignant Tumors2015284
Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research2013258
Targeting Macrophages in Cancer: From Bench to Bedside2018254
Altered tumor-cell glycosylation promotes metastasis2014242
The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism2012242
Role of Matrix Metalloproteinases in Angiogenesis and Cancer2019242
The KEAP1-NRF2 System in Cancer2017236
Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer2015225
Clinical Overview of MDM2/X-Targeted Therapies2016215
Radiation as an immunological adjuvant: current evidence on dose and fractionation2012214
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches2019214
Microtubules and their role in cellular stress in cancer2014213
Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology2016211
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification2017203
Targeting Oncogenic Mutant p53 for Cancer Therapy2015187
Control of the immune response by pro-angiogenic factors2014187